Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-11-22 7:9:46 am | FRLN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Freeline Therapeutics Holdings plc Is Fair to Shareholders | BusinessWire |
| 2023-11-22 4:30:0 am | Syncona to Acquire Freeline Therapeutics | GlobeNewswire |
| 2023-10-24 11:1:0 pm | Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress | GlobeNewswire |
| 2023-10-19 3:39:52 am | Here's Why We're A Bit Worried About Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation | Simply Wall St. |
| 2023-10-16 4:0:0 am | Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress | GlobeNewswire |
| 2023-10-04 4:0:0 am | Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information